How common are jaw problems with Prolia?
Prolia (denosumab) carries a risk of osteonecrosis of the jaw (ONJ), also called medication-related osteonecrosis of the jaw (MRONJ). This is bone death in the jaw that doesn't heal, often after dental procedures. The FDA label lists it as a warning, with incidence around 0.04% to 0.1% in osteoporosis trials (pooled data from 8,000+ patients over 3 years).[1] Real-world rates may reach 0.1-0.2% after 4+ years, higher with risk factors.[2]
What causes jaw osteonecrosis with Prolia?
Prolia blocks RANKL, reducing osteoclast activity to strengthen bones. This can impair jaw bone remodeling, especially under stress like tooth extractions or implants. Germs from oral infections may worsen it. Unlike bisphosphonates, Prolia clears faster from bone (half-life ~26 days in blood), but risk persists during treatment.[1][3]
Who is most at risk?
Higher odds with:
- Dental work (extractions: up to 4% risk in some studies).
- Poor oral health, smoking, or diabetes.
- Cancer patients on higher doses (2 mg/kg vs. 60 mg for osteoporosis; rates up to 1-2%).
- Long-term use (>4 years).[2][4]
Age over 65 or glucocorticoid use also elevates risk slightly.
What do symptoms look like?
Exposed jawbone, pain, swelling, infection, or loose teeth. It may start weeks to months after dental procedures. Not all cases need treatment; some resolve with antibiotics or conservative care, but surgery fails in 30-40%.[3]
How does Prolia's jaw risk compare to other bone drugs?
| Drug | Class | ONJ Risk (Osteoporosis Use) | Notes |
|------|--------|-----------------------------|-------|
| Prolia | RANKL inhibitor | 0.04-0.2% | Reverses faster post-stop than bisphosphonates. |
| Fosamax (alendronate) | Oral bisphosphonate | 0.01-0.1% | Stays in bone years after stopping. |
| Reclast (zoledronate) | IV bisphosphonate | 0.1-0.3% | Highest among osteoporosis drugs. |
| Evenity (romosozumab) | Sclerostin inhibitor | <0.1% | Lower reported cases. |
Prolia's risk sits mid-range; cancer doses spike it across all.[2][4]
What do doctors recommend to lower risk?
- Full dental check before starting; delay elective work.
- Good oral hygiene; report gum issues promptly.
- Pause Prolia 2-3 months before major dental surgery if high-risk (though evidence mixed).[1][3]
FDA advises monitoring; no routine drug holidays proven to prevent ONJ.
Can you get jaw problems after stopping Prolia?
Rare, but possible if ONJ started during use. Risk drops sharply after discontinuation unlike bisphosphonates.[3] Rebound bone loss occurs 6-12 months post-stop, but not linked to new ONJ.
[1]: FDA Prolia Label
[2]: Jaw in a Day Study (Schwartz et al., JADA 2021)
[3]: AAOMS Position Paper on MRONJ (2022)
[4]: Meta-analysis, Ruggiero et al., JOMS 2022